Literature DB >> 28337372

miR-429 mediates tumor growth and metastasis in colorectal cancer.

Yantao Han1, Qian Zhao2, Jie Zhou2, Rui Shi3.   

Abstract

Colorectal cancer (CRC), presenting the third most common malignancy worldwide. In recent years, the aberrantly upregulation or downregulation of miRNAs in CRC have been evidenced in a number of studies. In this study, our results showed that the expression of miR-429 was significantly higher in CRC tissue compared with adjacent non-tumor tissue. In addition, our findings showed that miR-429 level was significantly associated with clinicoplathological features and prognosis of patients with CRC. Moreover, our findings showed that miR-429 exerted oncogenic effect by directly targeting HOXA5, a transcription factor of HOX families that is involved in the development and progression of CRC.

Entities:  

Keywords:  CRC; HOXA5; MiR-429; metastasis; tumor growth

Year:  2017        PMID: 28337372      PMCID: PMC5336497     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  45 in total

1.  Knockdown of homeobox A5 by small hairpin RNA inhibits proliferation and enhances cytarabine chemosensitivity of acute myeloid leukemia cells.

Authors:  Na Li; Xiuhong Jia; Jianyong Wang; Youjie Li; Shuyang Xie
Journal:  Mol Med Rep       Date:  2015-09-15       Impact factor: 2.952

2.  miR-429 is involved in regulation of NF-κBactivity by targeting IKKβ and suppresses oncogenic activity in cervical cancer cells.

Authors:  Jing-Yi Fan; Ya-Jie Fan; Xiang-Ling Wang; Hong Xie; Hui-Jie Gao; Yi Zhang; Min Liu; Hua Tang
Journal:  FEBS Lett       Date:  2016-12-20       Impact factor: 4.124

3.  MiR-1297 regulates the growth, migration and invasion of colorectal cancer cells by targeting cyclo-oxygenase-2.

Authors:  Pu Chen; Bei-Li Wang; Bai-Shen Pan; Wei Guo
Journal:  Asian Pac J Cancer Prev       Date:  2014

4.  MiR-429 is an independent prognostic factor in colorectal cancer and exerts its anti-apoptotic function by targeting SOX2.

Authors:  Juan Li; Lutao Du; Yongmei Yang; Chuanxin Wang; Hui Liu; Lili Wang; Xin Zhang; Wei Li; Guixi Zheng; Zhaogang Dong
Journal:  Cancer Lett       Date:  2012-10-27       Impact factor: 8.679

5.  HOX genes in ovarian cancer.

Authors:  Zoë L Kelly; Agnieszka Michael; Simon Butler-Manuel; Hardev S Pandha; Richard Gl Morgan
Journal:  J Ovarian Res       Date:  2011-09-09       Impact factor: 4.234

6.  MiR-429 inhibits cells growth and invasion and regulates EMT-related marker genes by targeting Onecut2 in colorectal carcinoma.

Authors:  Yingnan Sun; Shourong Shen; Xiaoping Liu; Hailin Tang; Zeyou Wang; Zhibin Yu; Xiayu Li; Minghua Wu
Journal:  Mol Cell Biochem       Date:  2014-01-10       Impact factor: 3.396

Review 7.  Metastatic colorectal cancer-prolonging overall survival with targeted therapies.

Authors:  Satya Dattatreya
Journal:  South Asian J Cancer       Date:  2013-07

8.  HOXA5 determines cell fate transition and impedes tumor initiation and progression in breast cancer through regulation of E-cadherin and CD24.

Authors:  W W Teo; V F Merino; S Cho; P Korangath; X Liang; R-C Wu; N M Neumann; A J Ewald; S Sukumar
Journal:  Oncogene       Date:  2016-05-09       Impact factor: 9.867

9.  HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer).

Authors:  L Plowright; K J Harrington; H S Pandha; R Morgan
Journal:  Br J Cancer       Date:  2009-01-20       Impact factor: 7.640

10.  miR-429 functions as a tumor suppressor by targeting FSCN1 in gastric cancer cells.

Authors:  Min Zhang; Bing-Bin Dong; Min Lu; Mei-Juan Zheng; He Chen; Jing-Zhen Ding; A-Man Xu; Yuan-Hong Xu
Journal:  Onco Targets Ther       Date:  2016-03-03       Impact factor: 4.147

View more
  20 in total

1.  Study of KRAS-Related miRNA Expression in Colorectal Cancer.

Authors:  Xiaobing Wu; Zhifa Li; Nanqi Huang; Xiaodan Li; Rong Chen
Journal:  Cancer Manag Res       Date:  2022-10-17       Impact factor: 3.602

2.  LncRNA OIP5-AS1 promotes the malignancy of pancreatic ductal adenocarcinoma via regulating miR-429/FOXD1/ERK pathway.

Authors:  Liping Wu; Yongcun Liu; Cheng Guo; Yuan Shao
Journal:  Cancer Cell Int       Date:  2020-07-09       Impact factor: 5.722

3.  MicroRNA-429 sensitizes pancreatic cancer cells to gemcitabine through regulation of PDCD4.

Authors:  Gang Yu; Benli Jia; Yunsheng Cheng; Lianbang Zhou; Bo Qian; Zhining Liu; Yong Wang
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

4.  Long Non-coding RNA XIST Promotes Glioma Tumorigenicity and Angiogenesis by Acting as a Molecular Sponge of miR-429.

Authors:  Zhihua Cheng; Zhenshengnan Li; Ke Ma; Xiaoyu Li; Nan Tian; Jinyue Duan; Xu Xiao; Yi Wang
Journal:  J Cancer       Date:  2017-11-06       Impact factor: 4.207

Review 5.  Regulation of EMT in Colorectal Cancer: A Culprit in Metastasis.

Authors:  Trung Vu; Pran K Datta
Journal:  Cancers (Basel)       Date:  2017-12-16       Impact factor: 6.639

6.  HOXD3 targeted by miR-203a suppresses cell metastasis and angiogenesis through VEGFR in human hepatocellular carcinoma cells.

Authors:  Lumin Wang; Dongdong Tong; Qingqing Guo; Xiaofei Wang; Fei Wu; Qian Li; Juan Yang; Lingyu Zhao; Yannan Qin; Yingxun Liu; Chen Huang
Journal:  Sci Rep       Date:  2018-02-05       Impact factor: 4.379

7.  Correlation between miR-200 Family Overexpression and Cancer Prognosis.

Authors:  Wen Liu; Kaiping Zhang; Pengfei Wei; Yue Hu; Yaqin Peng; Xiang Fang; Guoping He; Limin Wu; Min Chao; Jing Wang
Journal:  Dis Markers       Date:  2018-07-04       Impact factor: 3.434

8.  Prognostic value of microRNAs in colorectal cancer: a meta-analysis.

Authors:  Song Gao; Zhi-Ying Zhao; Rong Wu; Yue Zhang; Zhen-Yong Zhang
Journal:  Cancer Manag Res       Date:  2018-04-30       Impact factor: 3.989

9.  MiR-629-5p promotes colorectal cancer progression through targetting CXXC finger protein 4.

Authors:  Jinlai Lu; Shuirong Lu; Jingze Li; Qi Yu; Lang Liu; Qin Li
Journal:  Biosci Rep       Date:  2018-08-29       Impact factor: 3.840

Review 10.  The miR-200 family: multiple effects on gliomas.

Authors:  Lilei Peng; Jie Fu; Yang Ming
Journal:  Cancer Manag Res       Date:  2018-07-13       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.